---
category: news
title: "Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer"
excerpt: "Median Technologies (Paris:ALMDT) (ALMDT), The Imaging Phenomics Company®, announces today the results of a preliminary retrospective study on the evaluation of the risk of recurrence for patients with primary liver cancer (HCC – hepatocellular carcinoma) based on a non-invasive biomarker."
publishedDateTime: 2020-06-17T15:45:00Z
webUrl: "https://www.businesswire.com/news/home/20200617005460/en/Median-Technologies-iBiopsy®-Promising-Results-Preliminary-Study"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://mms.businesswire.com/media/20200617005460/en/579686/23/Median_CMYK_tagline.jpg"
    width: 1200
    height: 627
    isCached: true
    title: "Median Technologies: iBiopsy®: Promising Results on a Preliminary Study to Evaluate the Risk of Tumor Recurrence in Patients With Primary Liver Cancer"

secured: "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;c73Y4d4XOjQd/LEPA6ychg=="
---

